98%
921
2 minutes
20
Antimicrobial photodynamic inactivation (aPDI) represents a promising alternative strategy for combating bacterial infections. This study investigates the potential of curcumin-loaded chitosan nanoparticles (CurChNPs) as novel nanoenabled photosensitizer agents for bacterial photoinactivation. CurChNPs were synthesized using an innovative dual synthesis approach by combination of nanoprecipitation and ionic gelation methods; their physicochemical properties were also characterized. The nanoparticles exhibited excellent solubility in aqueous solutions, high curcumin encapsulation efficiency (96%), and controlled release profile. Photoinactivation assays were conducted against (ATCC 25923) and (ATCC 25922) to evaluate the efficacy of CurChNPs in aPDI. The nanoparticles exhibited significant photobactericidal activity when irradiated with blue light (450 nm, 28.84 mW·cm). Mechanistic studies confirmed the generation of reactive oxygen species (ROS) as the primary mode of photoinactivation. Microscopy analyses revealed structural damage to bacterial cell membranes, culminating in cell lysis. These findings highlight the synergistic effects of the photodynamic activity of curcumin and the antimicrobial activity of chitosan, demonstrating that CurChNPs are a promising platform for the eradication of bacterial infections. This work contributes to the development of sustainable, nanotechnology-based approaches for addressing bacterial infections, particularly against resilient Gram-negative pathogens. Future studies may explore the potential of CurChNPs against antibiotic-resistant bacterial strains.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093364 | PMC |
http://dx.doi.org/10.1021/acsabm.5c00200 | DOI Listing |
J Appl Microbiol
September 2025
Sivas Cumhuriyet University, Faculty of Medicine, Department of Medical Microbiology, 58140 Sivas, Türkiye.
Aims: The increasing antimicrobial resistance, particularly in Acinetobacter baumannii, complicates the treatment of infections, leading to higher morbidity, mortality, and economic costs. Herein, we aimed to determine the in vitro antimicrobial, synergistic, and antibiofilm activities of colistin (COL), meropenem, and ciprofloxacin antibiotics, and curcumin, punicalagin, geraniol (GER), and linalool (LIN) plant-active ingredients alone and in combination against 31 multidrug-resistant (MDR) A. baumannii clinical isolates.
View Article and Find Full Text PDFJ Fish Dis
September 2025
Guangdong Provincial Water Environment and Aquatic Products Security Engineering Technology Research Center, Guangzhou Key Laboratory of Aquatic Animal Diseases and Waterfowl Breeding, College of Animal Sciences and Technology, Zhongkai University of Agriculture and Engineering, Guangzhou, Guangdong
Vibrio infections cause enteritis in grouper fish, leading to high mortality and stunted growth, which is a major challenge for aquaculture. Oligochitosans, marine prebiotics with bioactive properties, have proven their potential for growth promotion and immune regulation. However, the impacts of Vibrio harveyi on the gut microbiome of grouper fish and the potential of oligochitosans to modulate these effects remain poorly understood.
View Article and Find Full Text PDFEnviron Microbiol
September 2025
Listeria: Biology and Infection Research Group (LisBio), Valencia, Spain.
Listeria monocytogenes is a saprophytic bacterium and a foodborne pathogen of humans and animals. Little is known about its distribution and genetic diversity across different environments within the same geographical region. We conducted a large-scale longitudinal study in southeastern Spain monitoring Listeria spp.
View Article and Find Full Text PDFBasic Clin Pharmacol Toxicol
October 2025
Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Helicobacter
September 2025
Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Background: Several clinical studies have demonstrated that Helicobacter pylori (Hp) infection may exacerbate the progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD); however, the underlying mechanisms remain unclear. This study aims to investigate the characterization of the gastric microbiome and metabolome in relation to the progression of MASLD induced by Hp infection.
Methods: We established a high-fat diet (HFD) obese mouse model, both with and without Hp infection, to compare alterations in serum and liver metabolic phenotypes.